Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma

被引:14
|
作者
Kohno, Tomoko [1 ]
Yamada, Yasuaki [2 ]
Tawara, Masayuki [3 ]
Takasaki, Yumi [3 ]
Kamihira, Shimeru [2 ]
Tomonaga, Masao [3 ]
Matsuyama, Toshifumi [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Cytokine Signaling, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hematol, Nagasaki 8528523, Japan
关键词
ATLL; p14(ARF); p53; Pokemon; prognosis; CYCLE CONTROL GENES; TUMOR-SUPPRESSOR; LEUKEMIA-LYMPHOMA; INK4A LOCUS; METHYLATION; PROTEIN; P53; EXPRESSION; P19(ARF); PRODUCT;
D O I
10.1016/j.leukres.2006.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The INK4a/ARF locus encodes two different proteins, p16(INK4a) and p14(ARF), which are crucial for two tumor suppressor pathways. We found that p14(ARF) mRNA expression was suppressed in 13 of 37 cases, among which 9 cases showed the inactivation of both of p14(ARF) and p16(INK4a), and 4 cases showed the inactivation of p14(ARF) alone. The inactivation of p14(ARF) and the mutation of p53 are mutually exclusive. The patients with the p14(ARF) inactivation had shorter survival, similar to that of patients with the p53 mutation. These results indicate that the inactivation of p14(ARF) plays a key role in the progression of ATLL. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1625 / 1632
页数:8
相关论文
共 50 条
  • [1] Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma
    Ishida, E
    Nakamura, M
    Ikuta, M
    Shimada, K
    Matsuyoshi, S
    Kirita, T
    Konishi, N
    ORAL ONCOLOGY, 2005, 41 (06) : 614 - 622
  • [2] p14ARF methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma
    Davidovic, Radoslav
    Sopta, Jelena
    Mandusic, Vesna
    Krajnovic, Milena
    Stanojevic, Maja
    Tulic, Goran
    Dimitrijevic, Bogomir
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [3] p14ARF methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma
    Radoslav Davidović
    Jelena Sopta
    Vesna Mandušić
    Milena Krajnović
    Maja Stanojević
    Goran Tulić
    Bogomir Dimitrijević
    Medical Oncology, 2013, 30
  • [4] p14ARF methylation is a common event in the pathogenesis and progression of mixoid and pleomorphic liposarcoma
    Sopta, J.
    Davidovic, R.
    Kovacevic, R.
    Lujic, N.
    Ristic, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S15 - S16
  • [5] Inactivation of p14ARF and p53 are inversely correlated in human cell lines.
    Nicholson, SA
    Khan, MA
    Welsh, JA
    McMenamin, MG
    Travis, WD
    Harris, CC
    LABORATORY INVESTIGATION, 2001, 81 (01) : 212A - 212A
  • [6] Inactivation of p14ARF and p53 are inversely correlated in human cell lines.
    Nicholson, SA
    Khan, MA
    Welsh, JA
    McMenamin, MG
    Travis, WD
    Harris, CC
    MODERN PATHOLOGY, 2001, 14 (01) : 212A - 212A
  • [7] Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma
    Yamada, Y
    Kamihira, S
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1553 - 1559
  • [8] Frequent p16-independent inactivation of p14ARF in human melanoma
    Freedberg, Daniel E.
    Rigas, Sushila H.
    Russak, Julie
    Gai, Weiming
    Kaplow, Margarita
    Osman, Iman
    Turner, Faye
    Randerson-Moor, Juliette A.
    Houghton, Alan
    Busam, Klaus
    Bishop, D. Timothy
    Bastian, Boris C.
    Newton-Bishop, Julia A.
    Polsky, David
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (11): : 784 - 795
  • [9] Mechanisms of inactivation of p16INK4a & p14ARF in cutaneous squamous cell carcinoma
    Brown, VL
    Harwood, CA
    Crook, T
    Kelsell, DP
    Proby, CM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (03) : 752 - 752
  • [10] HYPERMETHYLATION OF p14ARF PROMOTER REGION AND EXPRESION OF p14ARF GENE PRODUCT IN NON-SMALL CELL LUNG CANCER
    田凯华
    沈毅
    罗宜人
    王明钊
    刘宏旭
    赵惠儒
    张林
    Chinese Journal of Cancer Research, 2006, (04) : 276 - 281